Robert E. Hoffman - 20 Oct 2026 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Reporting relationship: Chief Executive Officer
Issuer ticker: CYDY
Reported as of: 20 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Oct 2026, 20:28:47 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman

Filing notes and source

Key filing fact

Robert E. Hoffman filed Form 4 for CytoDyn Inc. (CYDY) on 20 Oct 2026.

Key facts

This page summarizes Robert E. Hoffman's Form 4 filing for CytoDyn Inc. (CYDY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Oct 2026, 20:28.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001166288 Primary reporting owner

Hoffman Robert E.

Relationship: Chief Executive Officer
Address: 1111 MAIN STREET, SUITE 660, VANCOUVER
Signature: /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman
Signature date: 20 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYDY transaction Derivative

Non-qualified stock option (right to buy)

Award

Transaction value
Shares: +2,500,000
Change %
Price: $0.000000^*
Shares after: 2,500,000
Date: 20 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,500,000
Exercise price: $0.2500
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This grant was approved by the Company's Compensation Committee on October 16, 2026, pursuant to the Issuer's 2012 Equity Incentive Plan (the "Plan").

Footnote F2

625,000 shares will vest on October 16, 2027, and the balance will vest in equal monthly installments beginning on November 16, 2027 and ending on October 16, 2030, subject to Continuous Service (as the term is defined in the Plan).